These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16686903)

  • 1. Experimental migraine models and their relevance in migraine therapy.
    Arulmani U; Gupta S; VanDenBrink AM; Centurión D; Villalón CM; Saxena PR
    Cephalalgia; 2006 Jun; 26(6):642-59. PubMed ID: 16686903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors.
    Gupta S; Villalón CM
    Pharmacol Ther; 2010 Oct; 128(1):170-90. PubMed ID: 20655327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovascular pharmacology of migraine.
    Maassenvandenbrink A; Chan KY
    Eur J Pharmacol; 2008 May; 585(2-3):313-9. PubMed ID: 18423447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: recent findings in animals].
    Mick G
    Pathol Biol (Paris); 2000 Sep; 48(7):593-607. PubMed ID: 11072637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
    Peroutka SJ
    Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier in migraine treatment.
    Edvinsson L; Tfelt-Hansen P
    Cephalalgia; 2008 Dec; 28(12):1245-58. PubMed ID: 18727638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.
    Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
    Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid.
    Knyihár-Csillik E; Toldi J; Krisztin-Péva B; Chadaide Z; Németh H; Fenyo R; Vécsei L
    Neurosci Lett; 2007 May; 418(2):122-6. PubMed ID: 17382471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of migraine: looking at the component parts of a complex disorder.
    Bergerot A; Holland PR; Akerman S; Bartsch T; Ahn AH; MaassenVanDenBrink A; Reuter U; Tassorelli C; Schoenen J; Mitsikostas DD; van den Maagdenberg AM; Goadsby PJ
    Eur J Neurosci; 2006 Sep; 24(6):1517-34. PubMed ID: 17004916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine pathophysiology and its clinical implications.
    Silberstein SD
    Cephalalgia; 2004; 24 Suppl 2():2-7. PubMed ID: 15595988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine.
    Benemei S; Nicoletti P; Capone JG; De Cesaris F; Geppetti P
    Handb Exp Pharmacol; 2009; (194):75-89. PubMed ID: 19655105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal models and their results in relation to the therapy of migraine].
    Kaube H; Limmroth V
    Schmerz; 1996 Jun; 10(3):114-20. PubMed ID: 12799856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes.
    Just S; Arndt K; Doods H
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):120-4. PubMed ID: 15882801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache: classification, mechanism and principles of therapy, with particular reference to migraine.
    Lance JW
    Recenti Prog Med; 1989 Dec; 80(12):673-80. PubMed ID: 2516913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic mechanisms in vascular headache.
    Moskowitz MA
    Neurol Clin; 1990 Nov; 8(4):801-15. PubMed ID: 2175382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical mechanisms in the physiopathology of migraine].
    Manivet P; Soliman HR; Callebert J; Laplanche JL; Launay JM
    Pathol Biol (Paris); 2000 Sep; 48(7):630-41. PubMed ID: 11072641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for novel migraine therapies: experimental models.
    Parsons AA; Bingham S
    Funct Neurol; 2000; 15 Suppl 3():36-42. PubMed ID: 11200799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of migraine: models to explain the generation of migraine headache].
    Ebersberger A
    Anaesthesist; 2002 Aug; 51(8):661-7. PubMed ID: 12391526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts of migraine pathophysiology.
    Hamel E
    Can J Clin Pharmacol; 1999; 6 Suppl A():9A-14A. PubMed ID: 10494006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.